The Food and Drug Administration has approved the world’s first medicine based on CRISPR gene-editing technology, a ...

Many high risk, high reward medical therapies that use cutting edge science are proving themselves in clinical trials. But are health services ready to pay for them—and how? Marianne Guenot reports On ...

Following a breakthrough 'cure' for sickle cell disease being approved on the NHS, the Mirror sat down with four British ...

When even one tiny section of a person’s genetic code becomes mutated or modified, cells can begin to act out of ...

Sickle cell disease, characterised by the abnormal sickle shape of red blood cells instead of the typical round form, is the UK's most rapidly expanding genetic disorder. This deformation causes ...

While de-extinction projects capture headlines with dreams of resurrecting mammoths, the same technologies at play — especially CRISPR — are quietly transforming something even more profound: human ...

The potential for cell and gene therapies is growing, offering groundbreaking treatments for rare genetic disorders and ...

Gene editing technologies have cemented their place as a valued method in the biological toolkit used by researchers around the globe.

The global gene therapy market is projected to grow at a significant CAGR of 20% from 2024 to 2029. This growth is driven by ...

Collaborative research defines a novel approach to understanding how certain proteins called transcription factors determine which genetic programs will drive cell growth and maturation. The method, ...